Unity Biotechnology, Inc.
OTC: UNBX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Craig R. Jalbert
- Employees
- 16
- Headquarters
- San Francisco, United States
- IPO year
- 2018
- Market cap
- $965.6K
- Website
- https://unitybiotechnology.com/pipeline/
Loading UNBX…
Loading profile data…Frequently asked questions about UNBX
What does Unity Biotechnology, Inc. (UNBX) do?
Unity Biotechnology, Inc. functions as a biotechnology enterprise dedicated to creating innovative treatments aimed at slowing down, stopping, or even reversing illnesses associated with the aging process. A core component of their therapeutic development involves senolytic compounds, specifically designed to address various ocular (eye) and neu...
Where does UNBX trade?
Unity Biotechnology, Inc. (UNBX) trades on the Other OTC.
What sector is UNBX in?
Unity Biotechnology, Inc. (UNBX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Unity Biotechnology, Inc.?
Craig R. Jalbert is the chief executive officer of Unity Biotechnology, Inc. (UNBX).
Where is Unity Biotechnology, Inc. headquartered?
Unity Biotechnology, Inc. is headquartered in United States.
Does UNBX pay a dividend?
Unity Biotechnology, Inc. (UNBX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did UNBX go public?
Unity Biotechnology, Inc. (UNBX) completed its initial public offering in 2018.